Spun out of the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA., Capillary Biomedical (CapBio) is a medical device firm developing technologies for diabetes management. Anchored in a license from Thomas Jefferson University, the firm is organized around dramatically simplifying glucose monitoring and insulin delivery, reducing the burden on both patients and the overall healthcare system. The goal is eventually to have developed a fully-implantable automated insulin delivery system consisting of an long-term continuous glucose monitor, insulin infusion pump and closed-loop control algorithm capable of automatically managing blood glucose. In July 2022 it was announced that Tandem Diabetes Care (Nasdaq: TNDM) had acquired Capillary Biomedical for an undisclosed amount. A global insulin delivery and diabetes technology company based in San Diego, CA, Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology.creates new possibilities for people living with diabetes through a positively different experience offering. a human-centered approach to design, development, and support delivering innovative products and services for people who use insulin.
